BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15850911)

  • 1. Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?
    Mollà M; Escude L; Nouet P; Popowski Y; Hidalgo A; Rouzaud M; Linero D; Miralbell R
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):118-24. PubMed ID: 15850911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
    Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
    Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible?
    Miralbell R; Mollà M; Arnalte R; Canales S; Vargas E; Linero D; Waters S; Nouet P; Rouzaud M; Escudé L
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):366-71. PubMed ID: 15145149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
    Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
    Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies.
    Wong E; D'Souza DP; Chen JZ; Lock M; Rodrigues G; Coad T; Trenka K; Mulligan M; Bauman GS
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):830-41. PubMed ID: 15708263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
    Aydogan B; Mundt AJ; Smith BD; Mell LK; Wang S; Sutton H; Roeske JC
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):266-73. PubMed ID: 16618581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
    Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a Phase I study.
    Macchia G; Cilla S; Ferrandina G; Padula GD; Deodato F; Digesù C; Caravatta L; Picardi V; Corrado G; Piermattei A; Valentini V; Cellini N; Scambia G; Morganti AG
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1390-5. PubMed ID: 19800180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
    Chong I; Hoskin PJ
    Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
    Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy.
    Beriwal S; Jain SK; Heron DE; Kim H; Gerszten K; Edwards RP; Kelley JL
    Gynecol Oncol; 2006 Aug; 102(2):195-9. PubMed ID: 16647748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.